Guglielmino Guy
Known title: Chief Commercial OfficerCIK: 0002047624
Associated companies
Transaction History
| TMCI | ▲ Buy | Grant | 150,000 | $0 | 1/22/2026 | View on chart |
| TMCI | ▼ Sell | Tax Withholding | 2,009 | $0 | 12/1/2025 | View on chart |
| TMCI | ▼ Sell | Tax Withholding | 20,090 | $0 | 12/1/2025 | View on chart |
| TMCI | ▲ Buy | Grant | 330,000 | $0 | 12/1/2024 | View on chart |
| TMCI | ▲ Buy | Grant | 33,000 | $0 | 12/1/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
Treace Medical Shares Five-Year Bunion Study Results
Treace Medical Concepts published five-year clinical results for its bunion treatment, aiming to strengthen evidence for broader adoption. This scientific update provides context for the stock's current position, which is trading near a key support level and below the average analyst price target.
Treace Medical Shares Five-Year Bunion Study Results. Treace Medical Concepts published five-year clinical results for its bunion treatment, aiming to strengthen evidence for broader adoption. This scientific update provides context for the stock's current position, which is trading near a key support level and below the average analyst price target.